Genetic variants in key necroptosis regulators predict prognosis of non-small cell lung cancer after surgical resection.

Jang Hyuck LeeJi Eun ParkMi Jeong HongJin Eun ChoiHyo-Gyoung KangSook Kyung DoSunwoong LeeJi Yun JeongKyung Min ShinYoung Woo DoEung Bae LeeWon Kee LeeIn Jae OhYoung-Chul KimSun Ha ChoiYong Hoon LeeHyewon SeoJaehee LeeSeung Ick ChaChang Ho KimSeung Soo YooShin-Yup Lee Jae Yong Park

Published in: Thoracic cancer (2023)

Two genetic variants in key regulators in necroptosis, RIPK1 rs17548629C > T and MLKL rs877375G > C, may be used as biomarkers to predict survival outcomes in surgically resected NSCLC patients.

Keyphrases

end stage renal disease
prognostic factors
small cell lung cancer
newly diagnosed
ejection fraction
chronic kidney disease
transcription factor
lymph node
peritoneal dialysis
patient reported outcomes
advanced non small cell lung cancer
patient reported